illumina-logo

The University of Maryland (UM) BioPark and Wexford Science & Technology, LLC, today announced Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems, as the newest tenant in the UM BioPark's 801 W. Baltimore St. building. The building is owned by Ventas, Inc., a life sciences real estate investment trust (REIT) and is part of Wexford's Knowledge Community development at the UM BioPark.

johnson-and-johnson-jlabs-logo

In honor of the new JLABS @ Washington, DC – a 32,000 square foot facility located on the new Children’s National Research and Innovation Campus from Johnson & Johnson Innovation, LLC in partnership with Children’s National Health System[1] (“Children’s National”) - Johnson & Johnson Innovation – JLABS announces the JLABS @ Washington, DC Children’s QuickFire Challenge.

Visionaries within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in total grant funding; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies.

women-in-bio-logo

Join Women In Bio-Capital Region for our annual summer networking picnic on Sunday, August 11th, 2019 from 10:00 a.m. to 1:00 p.m. Our chapter is providing the food and it will be brunch-style, under a lovely pavilion.

This is an open event, so please feel free to bring your family and friends for an opportunity to network and eat good food with your fellow WIB community. We look forward to seeing you at our upcoming annual summer networking picnic.

ampel-logo.jpg

CHARLOTTESVILLE, VA – AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic diseases, like Lupus. Revealed in the peer-reviewed journal Nature’s Scientific Reports, the paper details our breakthrough machine learning approach to predict disease activity from gene data obtained from patient blood samples. The lab test, only a concept for the last few years, is now ready for development for practical use. AMPEL’s initial focus was Lupus, but the test can be used for many autoimmune or inflammatory diseases.

AMPEL’s innovative machine learning approach, which is now ready to be developed as a decision support biomarker blood test could greatly impact health care, by allowing physicians to identify the cause of patient disease symptoms and select appropriate treatment more precisely. The application of our machine learning approach could assist pharmaceutical companies in drug development and clinical trials.

hrsa-logo

Do you have an innovative idea to help solve a health issue affecting moms and kids today? Here’s your chance to make it happen! The Maternal and Child Health Bureau (MCHB), part of the U.S. Health Resources and Services Administration (HRSA), invites you to participate in our four prize-awarded Challenges with a total prize purse of $1.5 million. These competitions seek low-cost, scalable, innovative solutions that improve the health of mothers and children across the U.S.

BioTracGovernorsCitation

On behalf of Bio-Trac, Co-Founder and Director Mark Nardone received a Governor’s Citation for Bio-Trac’s 33 years of service to the scientific community, having provided hands-on training to over 17,000 scientists. At last night’s well attended Stem Cell BioPanel event at the Montgomery College Bioscience Education Center, Mr. Nardone was caught by surprise, not knowing this award was to take place. In a heartfelt address, he mentioned to the audience of scientists that it was exactly the 1 year anniversary of Dr. Roland M Nardone’s passing and how he would have been pleased by the honor but even more so to see a room full of research scientists attending an event to gain knowledge, insight and network among their peers.

agt-hiv-logo

American Gene Technologies (AGT), a leading gene and cell therapy company based in Rockville, MD, selected the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) as a new clinical site for its non-IND study, AGT-CS168, to collect clinical specimens from HIV positive individuals. AGT will use these materials to validate the patient-specific AGT103-T therapeutic manufacturing process. AGT expects AGT103-T will eliminate HIV from the body when infused back into the patient and will decrease or eliminate the need for lifelong antiretroviral treatment.

tedco-2019-422-million-logo

The Maryland Technology Development Corporation (TEDCO), Maryland’s economic engine for technology companies, announced its recent investments through the Maryland Innovation Initiative (MII). With the latest round of funding, MII’s funding count for FY19 includes 26 technology assessment grants and seven start-up investments for a total of $4.22 million. True to its technology agnostic funding history, this year the startups ranged from Cleantech to AI and Biotech.

johns-hopkins-logo

Researchers at the Johns Hopkins Kimmel Cancer Center, the Greenberg Bladder Cancer Institute, the Bloomberg~Kimmel Institute for Cancer Immunotherapy, the Brady Urological Institute, and the Center for Computational Genomics at Johns Hopkins have received a $3.2 million grant from the National Institutes of Health to study new treatment options for early-stage bladder cancer.